社会职务：上海顺盈娱乐平台教授，博士生导师🐼，上海顺盈娱乐平台附属上海市肺科医院胸外科主任医师🧘🏻♂️🧑🦽、党委书记👩🏿⚖️，兰州大学萃英特聘教授。兼任中华医学会胸心血管外科学分会青年委员会副主任委员🎴、上海市医师协会胸外科分会副会长、海峡两岸医药卫生交流协会胸外科专业委员会副主任委员、上海医学会胸外科专科分会委员和美国胸外科学会Active Member等职务，享国务院特殊津贴。
学术兼职👳🏽♂️：《中华胸心和血管外科杂志》编委、《中国肺癌杂志》编委👱🏿♂️、《中国肿瘤杂志》编委，《Journal of Thoracic and Cardiovascular Surgery》、 《Annals of Thoracic Surgery》、 《Lung Cancer》、 《Clinical Lung Cancer》等杂志特约审稿专家。
SOCIAL POSITION:Chang Chen, Ph.D., M.D., candidate advisor and professor, is currently the vice president of Tongji University-affiliated Shanghai Pulmonary Hospital, chief physician of Thoracic Surgery of Tongji University-affiliated Shanghai Pulmonary Hospital and visiting professor of Lanzhou University School of Medicine. He is the deputy Chairman of the Youth Committee of the Chinese Medical Association Thoracic and Cardiovascular Surgery Branch, vice Chairman of the Thoracic Surgery Branch of the Shanghai Medical Doctor Association, deputy Chairman of the Association of medical exchanges across the Taiwan straits and a member of the Thoracic Surgery Branch of the Shanghai Medical Association. Additionally, he is an active member of American Thoracic Surgery Association and awarded special government allowances of the State Council.
ACADEMIC POSITION:He serves as the Editorial Board of Chinese Journal of Thoracic and Cardiovascular Surgery, Chinese Journal of Lung Cancer, Chinese Journal of Tumor; invited reviewer of Journal of Thoracic and Cardiovascular Surgery, Annals of Thoracic Surgery, Lung Cancer and Clinical Lung Cancer.
科研业绩总览:承担国家自然科学基金重大研究计划培育项目1项、面上项目2项及省部级项目课题10余项🟩，以通讯及共同通讯作者累计发表SCI论文70余篇，其中包括J Clin Oncol （IF=28.2），J Thorac Oncol（IF=12.5），JAMA Surg（IF=10.7），Mod Pathol（IF=6.4），JAMA Netw Open（IF=5.1）等，累计影响因子322分👩👩👦。编写胸部肿瘤外科专著7部，获得专利30项📗。2015年入选上海领军人才培养计划🫷🏻。荣获2018年教育部科学技术进步奖二等奖、2018年中华医学科技奖二等奖🙁、2017年中华医学科技奖二等奖和2016年上海医学科技奖二等奖等八项省部级奖项🤰🏽。
代表性论文：1. She Y, Jin Z, Wu J, Deng J, Zhang L, Su H, Jiang G, Liu H, Xie D, Cao N, Ren Y, Chen C (Co-corresponding author). Development and Validation of a Deep Learning Model for Non-Small Cell Lung Cancer Survival. JAMA Netw Open. 2020 Jun 1;3(6): e205842💁🏻♀️🩱；
2. Zhang L, Wang L, Kadeer X, Zeyao L, Sun X, Sun W, She Y, Xie D, Li M, Zou L, Rocco G, Yang P, Chen C (Corresponding author), Liu C C, Petersen R H, Ng C S H, Parrish S, Zhang Y S, Giordano R and di Tommaso L. Accuracy of a 3-Dimensionally Printed Navigational Template for Localizing Small Pulmonary Nodules: A Noninferiority Randomized Clinical Trial. JAMA Surg. 2018；
3. Dai C, Xie H, Su H, She Y, Zhu E, Fan Z, Zhou F, Ren Y, Xie D, Zheng H, Kadeer X, Chen D, Zhang L, Jiang G, Wu C and Chen C (Corresponding author). Tumor Spread through Air Spaces Affects the Recurrence and Overall Survival in Patients with Lung Adenocarcinoma >2 to 3 cm. J Thorac Oncol. 2017; 12(7): 1052-1060；
4. Dai C, Ren Y, Xie D, Zheng H, She Y, Jiang G, Fei K, Chen C (Corresponding author). Does lymph node metastasis have a negative prognostic impact in patients with NSCLC and M1a Disease? J Thorac Oncol. 2016; 11(10):1745-54👩🍳；
5. Dai C, Shen J, Ren Y, Zhong S, Zheng H, He J, Xie D, Fei K, Liang W, Jiang G, Yang P, Petersen RH, Ng C, Liu C, Rocco G, Brunelli A, Shen Y, Chen C (Co-corresponding author), He J. Choice of surgical procedure for patients with NSCLC ≤1 cm or >1 to 2 cm among lobectomy, segmentectomy and wedge resection: A population-based study. J Clin Oncol. 2016; 34(26): 3175-82.
授权专利代表：1.A METHOD FOR PRECISE LOCALIZATION AND TREATMENT OF A TARGET SITE AND A MEDCAL AUXILIARY APPARATUS （30041066）🙏🏻；
2.一种获取浸润性病灶概率的方法及系统（CN105726052B）🌛；
3.一种用于气管移植的新型纳米纤维膜纱支架（CN204106256U）；
4.一种3D打印的肺部小结节定位/活检辅助装置（CN207640489U）🧑🏽🎨；
5.一种可以用于上皮种植的新型纳米支架及其制备方法（CN102895701B）🧛♂️；
ACADEMIC ACHIEVEMENTS:Prof. Chen and his team are deeply involved in the entire course management and precise treatment of thoracic tumor surgery. Their goals are to realize translational medicine and improve therapeutic effects. He leads 17 research projects, including projects from the National Natural Science Foundation of China and has published more than 70 SCI papers as corresponding authors, including J Clin Oncol (IF= 28.2), J Thorac Oncol (IF=12.5), JAMA Surg (IF=10.7), Mod Pathol (IF=6.4), JAMA Netw Open (IF=5.1), etc. with a cumulative impact factor of 322 points. He compiled 7 monographs on thoracic tumor surgery and obtained 30 authorized patents.
In 2015, he was selected as a leading talent training program in Shanghai. In 2019, he was selected into the "National Hundreds and Thousands of Talents Project" plan, and won a total of 8 provincial and ministerial awards, including the second prize of the Ministry of Education Science and Technology Progress Award in 2018, the second prize of Chinese Medical Science and Technology Award in 2018, Chinese Medical Science and Technology Award in 2017, and Shanghai Medical Science and Technology Award in 2016.
B. Authorized Patents:1. A METHOD FOR PRECISE LOCALIZATION AND TREATMENT OF A TARGET SITE AND A MEDCAL AUXILIARY APPARATUS (30041066);2.A Method and system for obtaining the probability of invasive lesion (CN105726052B);3. A Novel Nanofiber Membrane/Scaffold for Tracheal Transplantation (CN204106256U);4.A 3D printed device for pulmonary nodule localization and biopsy (CN207640489U);5. A novel nano-scaffold for epithelial planting and its preparation method. (CN102895701B)
